绥美凯Triumeq和捷扶康Genvoya哪个更好
Which one is better, Genvoya?
Genvoya is indicated for the treatment of adults and adolescents (aged 12 years and older and weighing at least 35 kg) with human immunodeficiency virus-1 (HIV-1) infection and who do not have any known mutations associated with resistance to integrase inhibitors, emtricatidide or tenofovir.
TRIUMEQ (Dolutegravir Tablets, TRIUMEQ) is currently the only three-in-one compound drug containing dolutegravir (DrG), which integrates treatment drugs for different stages of viral infection into the same tablet. Patients only need to take one drug to achieve the effect of combined medication. This drug has always been effective in controlling HIV, and drug resistance is relatively rare.
Patients should go to the hospital for a detailed examination before receiving drug treatment. The doctor will recommend drugs and dosages based on the patient's stage of illness and personal constitution. Patients should not take medication blindly.
Triumeq is a fixed-dose tablet and should not be used in patients who require dose adjustments. If one of the active ingredients needs to be discontinued or dose adjustments made, separate formulations of dolutegravir, abacavir, or lamivudine may be used. In these circumstances, physicians should refer to the respective product information for these medicines. If a patient misses a dose of Triumeq and it is more than 4 hours before the next dose, Triumeq should be taken as soon as possible. If the next dose is less than 4 hours away, patients should not take the missed dose and simply resume their usual dosing schedule.
The main component of Triumeq (TRIUMEQ) is dolutea, which is currently a good drug for the treatment of human immunodeficiency virus. Although the drug is very effective, it is recommended that patients who require long-term medication need to regularly check their liver function. Once it is found that the liver is severely burdened by the medication, further combined medication treatment is required under the guidance of a doctor, or the medication can be changed to continue treatment.
The above is the introduction about it, I hope it can help everyone. If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service.
Recommended related hot articles: /newsDetail/80734.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)